|
|
|
Insider
Information: |
Caforio Giovanni |
Relationship: |
Director |
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
435,474 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$18,493,084 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
435,474 |
|
|
Total
Value |
$18,493,084 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
5
|
Stock
price went up :
|
0
|
3
|
Stock
price went down : |
0
|
2
|
|
|
|
Gain/Loss Ratio : |
0.0
|
1.5
|
Percentage
Gain/Loss : |
0.0%
|
1.8%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Bristol-Myers Squibb Co |
BMY |
Executive Chair of the... |
2024-03-10 |
432,266 |
|
0 |
Premium* |
|
Stryker Corp |
SYK |
Director |
2024-05-09 |
3,208 |
2023-05-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
119 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMY |
Bristol-Myers Squibb Co |
Chairman and CEO |
|
2018-03-10 |
4 |
D |
$67.92 |
$7,531,988 |
D/D |
(110,895) |
290,267 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Chairman and CEO |
|
2018-05-05 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,643) |
291,179 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Chairman and CEO |
|
2018-05-05 |
4 |
D |
$51.33 |
$161,484 |
D/D |
(3,146) |
288,033 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Chairman and CEO |
|
2019-03-10 |
4 |
D |
$51.39 |
$4,415,018 |
D/D |
(85,912) |
365,199 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Chairman and CEO |
|
2019-03-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(11,984) |
322,272 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Chairman and CEO |
|
2019-05-05 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,399) |
370,840 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Chairman and CEO |
|
2019-05-05 |
4 |
D |
$48.62 |
$134,872 |
D/D |
(2,774) |
368,066 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Chairman and CEO |
|
2020-03-10 |
4 |
D |
$57.93 |
$6,774,508 |
D/D |
(116,943) |
485,424 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Chairman and CEO |
|
2020-03-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,190) |
409,368 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Chairman and CEO |
|
2021-03-10 |
4 |
D |
$60.93 |
$6,838,357 |
D/D |
(112,233) |
553,980 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Chairman and CEO |
|
2021-03-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,635) |
473,453 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Board Chair and CEO |
|
2022-03-10 |
4 |
D |
$68.42 |
$10,871,254 |
D/D |
(158,890) |
606,524 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Board Chair and CEO |
|
2023-03-10 |
4 |
D |
$65.71 |
$9,067,257 |
D/D |
(137,989) |
367,935 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Executive Chair of the Board |
|
2024-03-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(57,536) |
479,917 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Executive Chair of the Board |
|
2024-03-10 |
4 |
D |
$53.79 |
$3,648,199 |
D/D |
(67,823) |
432,266 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Board Chair and CEO |
|
2022-03-22 |
4 |
GD |
$0.00 |
$0 |
D/D |
420 |
581,104 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Board Chair and CEO |
|
2023-10-10 |
4 |
GD |
$0.00 |
$0 |
D/D |
440 |
367,495 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Pres., US PharmaceuticalsOffic |
|
2011-10-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
38,818 |
|
- |
|
BMY |
Bristol-Myers Squibb Co |
Pres., US Pharmaceuticals |
|
2012-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,500 |
46,318 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Pres., US Pharmaceuticals |
|
2012-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,493 |
44,232 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Pres., US Pharmaceuticals |
|
2012-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,197 |
45,143 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Pres., US Pharmaceuticals |
|
2012-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,851 |
46,803 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Pres., US Pharmaceuticals |
|
2012-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,517 |
47,647 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Pres., US Pharmaceuticals |
|
2012-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,811 |
55,906 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Pres., US Pharmaceuticals |
|
2012-08-24 |
4 |
OE |
$23.18 |
$705,925 |
D/D |
30,458 |
83,160 |
0 |
- |
|
119 Records found
|
|
Page 3 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|